REDUCING BETA-CATENIN EXPRESSION TO POTENTIATE IMMUNOTHERAPY Application EP-3600423-A4 European Patent Office 13 Jan 2021
BETA-CATENIN INHIBITORS IN CANCER IMMUNOTHERAPY Application EP-3265179-A4 European Patent Office 18 Jul 2018